Drug details:
Molecular formula: C₃₀H₂₇LiN₂O₄S

Standard name: lithium;(3R)-6-(morpholin-4-ylmethyl)-7-(naphthalen-1-ylmethyl)-5-oxo-8-phenyl-2,3-dihydro-[1,3]thiazolo[3,2-a]pyridine-3-carboxylate

Curated SMILES: [Li+].C1COCCN1CC2=C(C(=C3N(C2=O)[C@H](CS3)C(=O)[O-])C4=CC=CC=C4)CC5=CC=CC6=CC=CC=C65

Evidence for compound's anti-virulence activity:

Escherichia
Related VF: Type 1 fimbriae; P fimbriae
Target: PapD
Drug effect: Blocking chaperone and usher functions.
Max phase: Preclinical (in vivo)
Publication:
Pinkner JS, et al., 2006. Rationally designed small compounds inhibit pilus biogenesis in uropathogenic bacteria. Proc Natl Acad Sci U S A 103(47):17897-902.